Acuta Capital Partners’s Zosano Pharma Corporation ZSAN Stock Holding History

Acuta Capital Partners’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-105	Closed	-$292K	–	86
2015 Q3	$292K	Sell	105 -20	-16%	-$112K	0.19%	56
2015 Q2	$632K	Buy	125 +94	+303%	+$581K	0.41%	43
2015 Q1	$222K	Buy	+31	New	+$233K	0.2%	49

Other funds holding ZSAN

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return